Phase I trial of emavusertib (CA-4948) in combination with cisplatin, gemcitabine, and durvalumab in patients with untreated advanced or metastatic biliary tract cancer.

Imfinzi (durvalumab) - AstraZeneca

gemcitabine - Generic mfg.

emavusertib (CA-4948) - Curis

cisplatin - Generic mfg.

Olivia Aranha; Gregory Fox; Vivian Ortiz; Melissa Meredith; Amberly Brown; Nicholas Waldron; Hailey Sappington; Jingxia Liu; Kian-huat Lim

Jul 17, 2026